TY - JOUR
T1 - Symposium
T2 - What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD?
AU - Capocchi, Joia K.
AU - Figueroa-Romero, Claudia
AU - Dunham, Sage J.B.
AU - Faraci, Gina
AU - Rothman, Jason A.
AU - Whiteson, Katrine L.
AU - Seo, Dong-oh
AU - Holtzman, David M.
AU - Grabrucker, Stefanie
AU - Nolan, Yvonne M.
AU - Kaddurah-Daouk, Rima
AU - Jett, David A.
N1 - Publisher Copyright:
Copyright © 2024 the authors.
PY - 2024/10/9
Y1 - 2024/10/9
N2 - Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRDs) are broad-impact multifactorial neurodegenerative diseases. Their complexity presents unique challenges for developing effective therapies. This review highlights research presented at the 2024 Society for Neuroscience meeting which emphasized the gut microbiome’s role in AD pathogenesis by influencing brain function and neurodegeneration through the microbiota–gut–brain axis. This emerging evidence underscores the potential for targeting the gut microbiota to treat AD/ADRD.
AB - Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRDs) are broad-impact multifactorial neurodegenerative diseases. Their complexity presents unique challenges for developing effective therapies. This review highlights research presented at the 2024 Society for Neuroscience meeting which emphasized the gut microbiome’s role in AD pathogenesis by influencing brain function and neurodegeneration through the microbiota–gut–brain axis. This emerging evidence underscores the potential for targeting the gut microbiota to treat AD/ADRD.
UR - http://www.scopus.com/inward/record.url?scp=85205990847&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.1295-24.2024
DO - 10.1523/JNEUROSCI.1295-24.2024
M3 - Article
C2 - 39384409
AN - SCOPUS:85205990847
SN - 0270-6474
VL - 44
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 41
M1 - e1295242024
ER -